 Iveric Bio Inc NASDAQ:ISEE stock is trading almost 50 higher as the investors are cheering Stifels initiated coverage on Iveric Bio with a Buy rating and a price target of 22.00. Analyst Annabel Samimy comments that, though the Company is not a first mover in the still untapped Geographic Atrophy GA market, Iveric could very well be the leading treatment for this indication. 